BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32089697)

  • 1.
    Raveendran S; Kumar G; Sivanandan RN; Dias M
    Int J Microbiol; 2020; 2020():7316257. PubMed ID: 32089697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
    Ejlertsen T; Skov R
    APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
    Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
    Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains.
    Kadry AA; Fouda SI; Elkhizzi NA; Shibl AM
    Int J Antimicrob Agents; 2003 Nov; 22(5):532-6. PubMed ID: 14602374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
    J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.
    Bootsma HJ; van Dijk H; Verhoef J; Fleer A; Mooi FR
    Antimicrob Agents Chemother; 1996 Apr; 40(4):966-72. PubMed ID: 8849261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.
    Wallace RJ; Steingrube VA; Nash DR; Hollis DG; Flanagan C; Brown BA; Labidi A; Weaver RE
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1845-54. PubMed ID: 2514622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis.
    Köseoglu O; Ergin A; Hascelik G
    Scand J Infect Dis; 2004; 36(6-7):431-4. PubMed ID: 15307563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.
    Levy F; Walker ES
    J Antimicrob Chemother; 2004 Feb; 53(2):371-4. PubMed ID: 14729761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
    Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
    J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.
    Balder R; Shaffer TL; Lafontaine ER
    BMC Microbiol; 2013 Jun; 13():140. PubMed ID: 23782650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases.
    Steingrube VA; Wallace RJ; Beaulieu D
    J Antimicrob Chemother; 1993 Feb; 31(2):237-44. PubMed ID: 8463169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.
    Eliasson I; Kamme C; Vang M; Waley SG
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):313-21. PubMed ID: 1396750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [beta-Lactamases of Branhamella catarrhalis and their phenotypic implications].
    Chaïbi EB; Mugnier P; Kitzis MD; Goldstein FW; Acar JF
    Res Microbiol; 1995; 146(9):761-71. PubMed ID: 8584798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer.
    Bootsma HJ; van Dijk H; Vauterin P; Verhoef J; Mooi FR
    Mol Microbiol; 2000 Apr; 36(1):93-104. PubMed ID: 10760166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
    McGregor K; Chang BJ; Mee BJ; Riley TV
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.
    Wallace RJ; Nash DR; Steingrube VA
    Am J Med; 1990 May; 88(5A):46S-50S. PubMed ID: 2111092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan.
    Ikeda F; Yokota Y; Mine Y; Yamada T
    Chemotherapy; 1993; 39(2):88-95. PubMed ID: 8458251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
    Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.
    Khan MA; Northwood JB; Levy F; Verhaegh SJ; Farrell DJ; Van Belkum A; Hays JP
    J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.